In Vitro Susceptibilty Test of Fluconazole to Candida spp in Patients with Oropharyngeal Candidiasis and HIV/AIDS with Vitek II
Downloads
Tschachler E, Bergstresser, Stingl G. HIV-related skin diseases. Lancet 1996; 348: 659-63.
Zanxanaro PCQ, McGrit LY, Mamelak AJ, Nguyen RHN, Martiins CR. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience. J Am Acad Dermatol 2006; 54: 581-8.
Wahyuli HN, Suyoso S, Prakoeswa CRS. Manifestasi klinis dan identifikasi spesies penyebab kandidiasis oral pada pasien HIV/AIDS di RSUD dr. Soetomo Surabaya. Berkala Ilmu Kesehatan Kulit dan Kelamin 2010; 22: 11-6.
Sobel JD, Akins RA. The role of resistance in Candida infections: Epidemiology and treatment. In Antimicrobial Drug Resistance 2017. Springer International Publishing. p. 1075-1097
Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Forthegill AW, Redding SW, et al. A randomized trial of continuous or intermittten therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patientes: clinical outcones and develompment of fluconazole resistance. Am J Med 1998; 105: 7-11.
Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis. JMM 2016; 26(1): 35-41.
Barchiesi F, Morbiducci V, Ancarani F, Scalise G. Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV infected patients. Eur J Epidemiol 1993; 9: 455-6.
Ben-Ami R, Giladi M. Fluconazole-resistant Candida: collateral damage associated with prior antibacterial exposure? Future Microbiol 2012;7(9): 1029-31.
Mane A. Panchvalli, Bembalkar S, Risbud A. Species distribution and antifungal susceptibility of oral Candida colonizing or infecting HIV infected individuals. Indian J Med Res 2010; 131: 836-8.
Zain ME, Mahdy HM, Hemdan MA. Increasing susceptibility of clinical isolates of candida species to azole antifungal drugs. J Appl Sci Res 2009; 5(10): 1325-34.
Hamza OJM, Matee MIN, Moshi MJ, Simon ENM, Mugusi F, Mikx FHM, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiology 2008; 8: 135.
Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, et al. Frequent detection of ‘azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC infectious disease 2013; 13: 82.
Guo H, Xie SM, Li SX, Song YJ, Zhong XY, Zhang H. Involvement of mitochondrial aerobic respiratory activity in efflux-mediated resistance of Candida albicans to fluconazole. JMM 2017. 19-21.
Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of candida albicans in patients with recurrent candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994; 32 (9): 2092-8.
Walmsley S, King S, McGeer A, Ye Y, Richardson S. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppresion. CID 2001; 32(11): 1554-61.
Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna E, Aniedobe M, et al. Fluconazole resistant opportunistic oro-pharyngeal candida and non candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. J. African H. Sci 2008; 8(3): 142-8.
Latiff AA, Banerjee U, Prasad R, Biswas A, Wig N, Mukhopadhyay G, et al.Susceptibility pattern and molecular typing of species-specific Candida in oropharyngeal lesion of Indian human immunodeficiencey virus-positive patient. J Clin Microbiol 2004; 42: 1260-2.
Astuti NF. Perbandingan Resistensi Candida albicans dan Candida non-albicans terhadap flukonazol dan nistatin (Kajian pada bilasan orofaring pasien dengan Human Immunodeficiency Virus di RSUD. Dr. Sardjito Yogyakarta). Thesis 2012.
Walangare T, Hidayat T, Basuki S. Profil Spesies Candida pada Pasien Kandidiasis oral dengan infeksi HIV & AIDS Berkala Ilmu Kesehatan Kulit Kelamin 2014; 26: 1-7.
Ditjen PPM & PL Depkes RI. Statistik kasus HIV/AIDS di Indonesia. Jakarta; 2013. Available from: http://depkes.go.id. Update 1 januari 2016.
Waleed AA, Rasheed RH, Karhoot JM. Prevalence of candida species and oral candidiasis during menstrual cycle in a sample of women in baghdad city. The iraqi postgraduate medical journal 2009; 1(1): 73-8.
Bajomo AS, Yusuf OA, Rudolph MJ, Tsotsi Norma. Impact of oral lesions among south african adult with HIV/AIDS on oral health-related quality of life. J. Dent. Sci 2013; 8: 412-17.
Dinas Kesehatan Provinsi Jawa Timur. Profil Kesehatan Provinsi Jawa Timur. Dinas Kesehatan Provinsi Jawa Timur 2013. Available from: URL: http://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_2013/15_Prov_Jatim_2013.pdf. Update 1 januari 2016.
Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, et al. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994; 8(7): 945-50.
Maurya V, Srivastava A, Mishra J, Gaind R, Marak RSK, Tripathi AK, et al. Oropharyngeal candidiasis and Candida colonization in HIV positive patients in northern India. J Infect Dev Ctries 2013; 7(8): 608-13.
Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK Westbrook SD, Louden C, et al. The changing epidemiology of oropharyngeal candidiasis in patients with HIV/AIDS in the era of antiretroviral therapy. AIDS Res Tret 2012; 2012: 262471.
Graf B, Adam T, Zill E, Göbe UB. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organism. J. Clin. Microbiol 2000; 38(5): 1782-5.
Meurman O, Koskensalo A, Rantakokko-Jalava K. Evaluation of Vitek 2 for identification of yeasts in the clinical laboratory. Clin Microbiol Infect 2006; 12: 591–3.
Hamza OJ, Matee IM, Moshi MJ, Simon ENM, Mugusi F, Mikx FHM, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol 2008; 8: 135.
Borghi E, Iatta R, Sciota R, Biassoni C, Cuna T, Montagna MT, et al. GISIA3 study antifungal susceptibility of invasive fungal microdilution reference method for testing susceptibility test and CLSI broth comparative evaluation of the Vitek 2 yeast. J Clin Microbiol 2010, 48(9): 3153-7.
Rodríguez-Tudela JL, Almirante B, Rodríguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, et al. Correlation of the MIC and Dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. Antimicrob Agents Chemother 2007; 51(10): 3599–604.
Redding SW, Kirkpatrick WR, Saville S, Coco BJ, White W, Fothergill A. multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol 2003; 41(2): 619–22.
Pereaand S, Patterson TF. Antifungal resistance in pathogenic fungi. Clin Infect Dis 2002; 35(9): 1073-80.
Shantanam J, Yahaya N, Aziz MN. Species distribution and antifungal susceptibility patterns of Candida species: is low susceptibility to itraconazole a trend in Malaysia?. Med J Malaysia 2013; 68(4): 343-7.
Orozco AS, Higginbotham LM, Hitchcock CA, Parkinson T, Falconer D, Ibrahim AS, et al. Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother 1998; 42(10): 2645-9.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
